This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.
What happened
Monster retailer Amazon (NASDAQ: AMZN) doesn’t often lose, so shareholders get discouraged when the company doesn’t come in first in a contest. That was the situation on Tuesday, when a rival’s bid was selected for a big healthcare asset that was in play. As a result, Amazon’s share price closed the day over 1% lower, a steeper fall than that of the S&P 500 index.
So what
Amazon was vying for healthcare services company Signify Health, but the nod ended up going to CVS Health, whose bid was worth roughly $8 billion. Other companies participating in the effort to acquire Signify were UnitedHealth Group and Option Care Health.
Among that crowd, Amazon was a bit of an outlier. UnitedHealth and Option Care are pure-play healthcare companies. Amazon, which has always aimed to be a retailer of any product or service imaginable, is still considered by many to be more of a giant online shopping outlet than a provider of healthcare services.
In Signify’s press release announcing its selection of CVS, CEO Kyle Armbrester said that “we determined that CVS Health is the ideal partner, given its focus on expanding access to health services and helping consumers navigate to the best sites of care.”
While Amazon has indisputably made strides in its medical business efforts — witness its $3.9 billion deal for primary care provider 1Life Healthcare earlier this year — it still isn’t readily identified with that sector. It wouldn’t be surprising if this made the company a dark horse candidate, at best, in the Signify bidding.
Now what
Amazon isn’t known for setbacks and management probably isn’t too fond of them, so we can expect the company to make fresh bids for other healthcare businesses that come into play. But other entities with deep pockets will also be looking to buy, so Signify might not be the last of its defeats in the sector.
This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.
The post Why Amazon stock stumbled today appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now
See The 5 Stocks *Returns as of August 4 2022
More reading
- If you like Amazon, you’ll love these 3 stocks
- Is Alphabet stock a buy after Q2 earnings?
- Why the Amazon share price slumped on Tuesday
- Why Amazon’s latest green hydrogen partnership is a big deal
- 2 genius reasons to buy Amazon stock today
John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Foolâs board of directors. Eric Volkman has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Amazon. The Motley Fool Australia has recommended Amazon. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.
from The Motley Fool Australia https://ift.tt/esMjlqu
Leave a Reply